Diet, alcohol, tobacco and risk of cancer of the pancreas: a case-control study.

por Durbec, J. P., Chevillotte, G., Bidart, J. M., Berthezene, P., Sarles, H.
Publicado 1983

Chromogranin A and the α -subunit of glycoprotein hormones in medullary thyroid carcinoma and phaeochromocytoma

por Guignat, L, Bidart, J M, Nocera, M, Comoy, E, Schlumberger, M, Baudin, E
Publicado 2001

Gene expression profiling identifies Fibronectin 1 and CXCL9 as candidate biomarkers for breast cancer screening

por Ruiz-Garcia, E, Scott, V, Machavoine, C, Bidart, J M, Lacroix, L, Delaloge, S, Andre, F
Publicado 2010

Neuron-specific enolase and chromogranin A as markers of neuroendocrine tumours.

por Baudin, E., Gigliotti, A., Ducreux, M., Ropers, J., Comoy, E., Sabourin, J. C., Bidart, J. M., Cailleux, A. F., Bonacci, R., Ruffié, P., Schlumberger, M.
Publicado 1998

Summary report of the Standards, Options and Recommendations for the use of serum tumour markers in breast cancer: 2000

por Basuyau, J P, Blanc-Vincent, M P, Bidart, J M, Daver, A, Deneux, L, Eche, N, Gory-Delabaere, G, Pichon, M F, Riedinger, J M
Publicado 2003

ROS-generating NADPH oxidase NOX4 is a critical mediator in oncogenic H-Ras-induced DNA damage and subsequent senescence

por Weyemi, U, Lagente-Chevallier, O, Boufraqech, M, Prenois, F, Courtin, F, Caillou, B, Talbot, M, Dardalhon, M, Al Ghuzlan, A, Bidart, J-M, Schlumberger, M, Dupuy, C
Publicado 2012

Candidate epitopes for measurement of hCG and related molecules: the second ISOBM TD-7 workshop

por Berger, P., Paus, E., Hemken, P. M., Sturgeon, C., Stewart, W. W., Skinner, J. P., Harwick, L. C., Saldana, S. C., Ramsay, C. S., Rupprecht, K. R., Olsen, K. H., Bidart, J.-M., Stenman, U.-H.
Publicado 2013